Contribute Try STAT+ Today

WASHINGTON — Republicans in Congress are working to relax a law that would force drug makers to pay a higher percentage of costs for Medicare beneficiaries.

Democratic aides, including in House leadership, and a spate of health industry lobbyists confirmed that House Republicans are trying to use an upcoming spending bill to make the change at the behest of the pharmaceutical industry, which has spent the weeks since the law was enacted in February blasting the policy. Whether the industry can agree to the particulars of a “fix” before a March 23 deadline and whether Democrats will accept the policy is still up in the air.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.